It drives me batty (ok, even more batty then), when we get good news and the SP goes down...
Then we get bad news and the share price goes down.
There are a whole stack on here that weren't around at the middle of 2019...then we would get good news and the share price went up....stayed up...and it kept going up!
Yeah that above is not $1.70 going to $1.73....that's going to $4 plus, in how many months?
This time will come again, I dunno when, I presume it's still a while away. But at some stage instos will start looking into us and will start buying off predominantly, retail...
We will eventually get more stability and our market cap will start to grow.
Initiation of new coverage.
Dimerix style regional deals...more good data after a year or two....and then material deals.
I could be wrong, there is still risk.
We won't always be suppressed as long as we show super consistency and plough through the final trials.
DYOR as per usual
- Forums
- ASX - By Stock
- PAR
- Ann: Notice of General Meeting/Proxy Form
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
6.45%
!
29.0¢

Ann: Notice of General Meeting/Proxy Form, page-80
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $114.8M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $67.39K | 220.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 396 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 0.290 |
6 | 95688 | 0.285 |
20 | 268416 | 0.280 |
7 | 73263 | 0.275 |
6 | 106424 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 16229 | 4 |
0.305 | 2746 | 1 |
0.310 | 62705 | 4 |
0.315 | 59233 | 3 |
0.320 | 108906 | 8 |
Last trade - 12.55pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online